Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)
109.48
-1.67 (-1.50%)
At close: Oct 1, 2026
NSE:GAUDIUMIVF Revenue
Gaudium IVF and Women Health had revenue of 193.77M INR in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 1.06B, up 49.85% year-over-year. In the fiscal year ending March 31, 2026, Gaudium IVF and Women Health had annual revenue of 1.04B with 47.56% growth.
Revenue (ttm)
1.06B
Revenue Growth
+49.85%
P/S Ratio
7.52
Revenue / Employee
8.83M
Employees
120
Market Cap
7.97B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.04B | 336.33M | 47.56% |
| Mar 31, 2025 | 707.24M | 228.34M | 47.68% |
| Mar 31, 2024 | 478.90M | 36.35M | 8.21% |
| Mar 31, 2023 | 442.55M | 77.36M | 21.18% |
| Mar 31, 2022 | 365.20M | 303.45M | 491.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Indraprastha Medical Corporation | 15.24B |
| Shalby | 11.76B |
| Artemis Medicare Services | 11.14B |
| Nephrocare Health Services | 10.53B |
| Jeena Sikho Lifecare | 8.51B |
| GPT Healthcare | 4.92B |
| Max India | 2.39B |
| Unihealth Hospitals | 1.32B |